These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
78 related items for PubMed ID: 355684
1. Production of trypsin-activable toxic components by Clostridium botulinum types C and D [proceedings]. Nakane A, Oguma K, Shiozaki M, Iida H. Jpn J Med Sci Biol; 1978 Apr; 31(2):166-9. PubMed ID: 355684 [No Abstract] [Full Text] [Related]
3. Phage-conversion of toxigenicity in Clostridium botulinum types C and D. Inoue K, Iida H. Jpn J Med Sci Biol; 1971 Feb; 24(1):53-6. PubMed ID: 4931809 [No Abstract] [Full Text] [Related]
4. Bacteriophages and Toxigencity in Clostridium Botulinum types C and D. Oguma K, Iida H, Inove K. Schweiz Med Wochenschr; 1975 Dec 20; 105(51):548-52. PubMed ID: 766180 [No Abstract] [Full Text] [Related]
8. Production of C2 toxin by Clostridium botulinum types C and D as determined by its vascular permeability activity. Ohishi I, Sakaguchi G. Infect Immun; 1982 Jan 20; 35(1):1-4. PubMed ID: 7033132 [Abstract] [Full Text] [Related]
9. [Toxigenicity and bacteriophages of Clostridium botulinum]. Oguma K. Nihon Saikingaku Zasshi; 1974 Jul 20; 29(4):665-9. PubMed ID: 4613878 [No Abstract] [Full Text] [Related]
10. The taxonomic position of Clostridium botulinum type c. Jansen BC, Knoetze PC. Onderstepoort J Vet Res; 1977 Jun 20; 44(2):53-4. PubMed ID: 351507 [Abstract] [Full Text] [Related]
11. [Ultrastructure of Clostridium botulinum type E during the process of toxin formation]. Lysenko AI, Cherniavskiĭ VI, Kulakova GS, Iskritskiĭ GV. Mikrobiol Zh; 1973 Jun 20; 35(3):308-12. PubMed ID: 4598684 [No Abstract] [Full Text] [Related]
12. [Toxigenicity and bacteriophage in Clostridium botulinum (author's transl)]. Iida H. Tanpakushitsu Kakusan Koso; 1976 Nov 20; Suppl():31-44. PubMed ID: 800280 [No Abstract] [Full Text] [Related]
13. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history. Oguma K, Iida H. J Gen Microbiol; 1979 May 20; 112(1):203-6. PubMed ID: 383896 [Abstract] [Full Text] [Related]
14. The stability of toxigenicity in Clostridium botulinum types C and D. Oguma K. J Gen Microbiol; 1976 Jan 20; 92(1):67-75. PubMed ID: 1107486 [Abstract] [Full Text] [Related]
16. Growth and toxin production of Clostridium botulinum types E, nonproteolytic B, and F in nonirradiated and irradiated fisheries products in the temperature range of 36 degrees to 72 degrees F. TID-24881. Eklund MW, Poysky FT, Wieler DI. TID Rep; 1966 Jan 14; ():1-86. PubMed ID: 4905224 [No Abstract] [Full Text] [Related]
17. Proteases of Clostridium botulinum. VI. The role of trypsin, Clostridium botulinum proteases and protease inhibitors in the formation and activation of toxin in growing cultures of Clostridium botulinum. Tjaberg TB. Acta Vet Scand; 1974 Jan 14; 15(4):487-506. PubMed ID: 4616624 [Abstract] [Full Text] [Related]
18. Expression and stability of the nontoxic component of the botulinum toxin complex. Miyata K, Yoneyama T, Suzuki T, Kouguchi H, Inui K, Niwa K, Watanabe T, Ohyama T. Biochem Biophys Res Commun; 2009 Jun 19; 384(1):126-30. PubMed ID: 19394306 [Abstract] [Full Text] [Related]